BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7480674)

  • 1. SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG).
    Drane WE; Nicole MW; Mastin ST; Kuperus JH
    Radiology; 1995 Nov; 197(2):341-2; discussion 343. PubMed ID: 7480674
    [No Abstract]   [Full Text] [Related]  

  • 2. Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET.
    Macfarlane DJ; Cotton L; Ackermann RJ; Minn H; Ficaro EP; Shreve PD; Wahl RL
    Radiology; 1995 Feb; 194(2):425-9. PubMed ID: 7824722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor diagnosis using 18F-FDG SPECT].
    Sugiyama S; Suzuki Y; Matsuzaki H; Tomiyoshi K; Endo K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Aug; 56(9):679-80. PubMed ID: 8831228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technology for FDG SPECT with a relatively inexpensive gamma camera. Work in progress.
    Drane WE; Abbott FD; Nicole MW; Mastin ST; Kuperus JH
    Radiology; 1994 May; 191(2):461-5. PubMed ID: 8153322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation dose to the bladder wall from 2-[18F]fluoro-2-deoxy-D-glucose in adult humans.
    Dowd MT; Chen CT; Wendel MJ; Faulhaber PJ; Cooper MD
    J Nucl Med; 1991 Apr; 32(4):707-12. PubMed ID: 2013811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revealing biochemistry in a single image.
    Coleman RE
    J Nucl Med; 1995 Sep; 36(9):32N-33N. PubMed ID: 7658244
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluorine-18-deoxyglucose SPECT and coincidence imaging for myocardial viability: Clinical and technologic issues.
    Dilsizian V; Bacharach SL; Khin MM; Smith MF
    J Nucl Cardiol; 2001; 8(1):75-88. PubMed ID: 11182712
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose.
    Martin WH; Delbeke D; Patton JA; Sandler MP
    Radiology; 1996 Jan; 198(1):225-31. PubMed ID: 8539384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-energy (511-keV) imaging with the scintillation camera.
    Patton JA; Sandler MP; Ohana I; Weinfeld Z
    Radiographics; 1996 Sep; 16(5):1183-94. PubMed ID: 8888397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine 18F-2-deoxy-2-fluoro-D-glucose (18F-FDG) myocardial tomography using a normal large field of view gamma-camera.
    Höflin F; Ledermann H; Noelpp U; Weinreich R; Rösler H
    Angiology; 1989 Dec; 40(12):1058-64. PubMed ID: 2596740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations of breast tumors with fluorine-18-fluorodeoxyglucose and SPECT.
    Holle LH; Trampert L; Lung-Kurt S; Villena-Heinsen CE; Püschel W; Schmidt S; Oberhausen E
    J Nucl Med; 1996 Apr; 37(4):615-22. PubMed ID: 8691251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New equipment in nuclear medicine, part 2: dual-head FDG coincidence detection cameras.
    Ketchum LE
    J Nucl Med; 1999 Mar; 40(3):9N-10N, 13N, 17N-18N passim. PubMed ID: 10086694
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluorine-18-fluorodeoxyglucose cardiac imaging using a modified scintillation camera.
    Sandler MP; Bax JJ; Patton JA; Visser FC; Martin WH; Wijns W
    J Nucl Med; 1998 Dec; 39(12):2035-43. PubMed ID: 9867138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Images in neuroscience. Neuroimaging, I.PET with [18F]fluorodeoxyglucose.
    Tamminga CA
    Am J Psychiatry; 1995 Oct; 152(10):1415. PubMed ID: 7573578
    [No Abstract]   [Full Text] [Related]  

  • 15. Iodine-123-labeled glucose analogs: prospects for a single-photon-emitting analog of fluorine-18-labeled deoxyglucose.
    Gatley SJ
    Nucl Med Biol; 1995 Oct; 22(7):829-35. PubMed ID: 8547880
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of myocardial glucose utilization of hypertrophic and dilated cardiomyopathy using 18F-2-fluoro 2-deoxy-D-glucose and positron emission tomography].
    Ohtake T; Kosaka N; Watanabe T; Momose T; Nishikawa J; Sasaki Y; Iio M; Yokoyama I; Iizuka M; Sugimoto T
    Nihon Rinsho; 1991 Jan; 49(1):143-7. PubMed ID: 2002593
    [No Abstract]   [Full Text] [Related]  

  • 17. Positron-emission tomographic scanning of primary and metastatic breast carcinoma with the radiolabeled glucose analogue 2-deoxy-2-[18F]fluoro-D-glucose.
    Wahl RL; Cody R; Hutchins G; Mudgett E
    N Engl J Med; 1991 Jan; 324(3):200. PubMed ID: 1984203
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of oncology protocol using fluorine-18-FDG: one center's experience.
    Cronin V; Galantowicz P; Nabi HA
    J Nucl Med Technol; 1997 Mar; 25(1):66-9. PubMed ID: 9239608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer treatment monitoring with fluorine-18 2-fluoro-2-deoxy-D-glucose and positron emission tomography: frustration or future.
    Minn H; Paul R
    Eur J Nucl Med; 1992; 19(11):921-4. PubMed ID: 1425778
    [No Abstract]   [Full Text] [Related]  

  • 20. F-18 FDG uptake by recurrent Hürthle cell carcinoma of the thyroid using high-energy planar scintigraphy.
    Blount CL; Dworkin HJ
    Clin Nucl Med; 1996 Nov; 21(11):831-3. PubMed ID: 8922841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.